The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

Goodnight’s ongoing decision to keep SAS private has shaped the company that — more than any other — has shaped the town of ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

Last week, it was announced that Genentech, a founding company in the biotech industry, plans to build a $700 million, ...

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...

Headlines across North Carolina Monday and Tuesday included 400 new jobs in Holly Springs; flooding risk in the mountains eases; Congressman Chuck Edwards accused for hitting someone with a clipboard ...

Governor Josh Stein announced Monday that Genentech, one of the world’s premiere biotechnology companies, will invest $700 ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

North Carolina Gov. Josh Stein announced that Genentech, a biotechnology company, will build a new manufacturing plant in Wake County, creating 420 jobs.

Genentech, a Bay Area-based biotech firm and member of the Switzerland-based Roche Group, plans to develop a $700 million pharmaceutical manufacturing facility in Holly Springs, approximately 20 miles ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.